Assistant Professor of Psychiatry Johns Hopkins University School of Medicine
The FDA approval for Psychedelics treatments is on the horizon. Safe and therapeutic use of these medications will require extensive education for prescribers and psychotherapists alike. However, the majority of clinicians receive no formal education in this emerging therapeutic modality. This session will describe essential elements of training in psychedelic medicine and describe how that education can be integrated into existing academic training programs.